- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 14, 2025 | 46.48M sh |
| Capex | Q3 2025 · Mar 31, 2025 | $0 |
| Capex | Q3 2025 · Mar 31, 2024 | $37.62K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $2.52M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $10.05M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $9.66M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $10.12M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $10.85M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $3.23M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $9.77M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $3.73M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $10.74M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $1.47M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $5.18M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.03M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $8.27M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 15.79M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 14.01M sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$24.99M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $1.58M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$11.38M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | −$1.98M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.53 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$1.53 |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $7.16M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $17.73M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$8.44M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$21.49M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$9.22M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$14.15M |